US2010167398A1PendingUtilityA1
Method of culturing pluripotent stem cells using extracellular matrix from fetal membrane-derived cells
Est. expiryDec 24, 2028(~2.4 yrs left)· nominal 20-yr term from priority
A61P 43/00C12N 2533/92C12N 5/0606C12N 5/0696
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are a method of culturing pluripotent stem cells in the presence of a decidua-derived cell or an extracellular matrix derived from the cell, that enables safe and efficient maintenance culture and derivation of pluripotent stem cells; a culture agent for pluripotent stem cells, that comprises a decidua-derived cell or an extracellular matrix derived from the cell; and other means for developing or performing the method.
Claims
exact text as granted — not AI-modified1 . A method of culturing pluripotent stem cells in the presence of decidua-derived cells or an extracellular matrix derived from the cell.
2 . The method according to claim 1 , wherein the decidua-derived cell is a mesenchymal cell.
3 . The method according to claim 1 , wherein both the decidua-derived cell and the pluripotent stem cells are derived from a mammal of the same species.
4 . The method according to claim 3 , wherein the mammal is a human.
5 . The method according to claim 1 , wherein the pluripotent stem cells are human ES cells or human iPS cells.
6 . A culture agent for pluripotent stem cells, containing decidua-derived cells or an extracellular matrix derived from the cell.
7 . The agent according to claim 6 , wherein the decidua-derived cell is a mesenchymal cell.
8 . The agent according to claim 6 , wherein both the decidua-derived cell and the pluripotent stem cells are derived from a mammal of the same species.
9 . The agent according to claim 8 , wherein the mammal is a human.
10 . The agent according to claim 6 , wherein the pluripotent stem cells are human ES cells or human iPS cells.
11 . A container for culturing pluripotent stem cells, coated with an extracellular matrix from decidua-derived cells.
12 . The container according to claim 11 , wherein the decidua-derived cell is a mesenchymal cell.
13 . The container according to claim 11 , wherein both the decidua-derived cell and the pluripotent stem cells are derived from a mammal of the same species.
14 . The container according to claim 13 , wherein the mammal is a human.
15 . The container according to claim 11 , wherein the pluripotent stem cells are human ES cells or human iPS cells.
16 . A kit for culturing pluripotent stem cells, comprising (i) and (ii) below:
(i) a culture agent for pluripotent stem cells, comprising decidua-derived cells or an extracellular matrix derived from the cell; and (ii) an explanatory document stating that the kit should be used, or can be used, for culturing pluripotent stem cells.
17 . A kit for culturing pluripotent stem cells, comprising (i) and (ii) below:
(i) a container for culturing pluripotent stem cells, coated with an extracellular matrix from decidua-derived cells; and (ii) an explanatory document stating that the kit should be used, or can be used, for culturing pluripotent stem cells.Join the waitlist — get patent alerts
Track US2010167398A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.